NYSE:ASPN - アナリストの将来予測と過去の財務データ ( )USD Millions
日付	収益	収益	フリー・キャッシュフロー	営業活動によるキャッシュ	平均アナリスト数
12/31/2026	768	99	24	148	5
12/31/2025	562	51	-187	106	8
12/31/2024	387	4	-51	41	6
3/31/2024	288	-31	-188	-36	N/A
12/31/2023	239	-46	-218	-43	N/A
9/30/2023	214	-55	-270	-64	N/A
6/30/2023	190	-71	-335	-94	N/A
3/31/2023	188	-80	-309	-96	N/A
12/31/2022	180	-83	-272	-94	N/A
9/30/2022	152	-89	-209	-82	N/A
6/30/2022	146	-68	-113	-51	N/A
3/31/2022	132	-50	-66	-40	N/A
12/31/2021	122	-37	-32	-19	N/A
9/30/2021	113	-27	-19	-12	N/A
6/30/2021	107	-26	-13	-7	N/A
3/31/2021	100	-25	-14	-10	N/A
12/31/2020	100	-22	-13	-10	N/A
9/30/2020	124	-17	-3	0	N/A
6/30/2020	135	-12	-5	-2	N/A
3/31/2020	140	-12	-2	1	N/A
12/31/2019	139	-15	-3	-1	N/A
9/30/2019	129	-28	-8	-6	N/A
6/30/2019	117	-32	-8	-4	N/A
3/31/2019	109	-34	-13	-9	N/A
12/31/2018	104	-34	-12	-9	N/A
9/30/2018	105	-22	-12	-8	N/A
6/30/2018	108	-19	-8	-5	N/A
3/31/2018	112	-17	-7	-3	N/A
12/31/2017	112	-19	N/A	-5	N/A
9/30/2017	103	-23	N/A	-4	N/A
6/30/2017	105	-23	N/A	-1	N/A
3/31/2017	108	-19	N/A	-5	N/A
12/31/2016	118	-12	N/A	-1	N/A
9/30/2016	127	-5	N/A	4	N/A
6/30/2016	129	-4	N/A	1	N/A
3/31/2016	132	-5	N/A	9	N/A
12/31/2015	123	-6	N/A	5	N/A
9/30/2015	113	-11	N/A	5	N/A
6/30/2015	107	-11	N/A	6	N/A
3/31/2015	104	-50	N/A	2	N/A
12/31/2014	102	-66	N/A	7	N/A
9/30/2014	99	-64	N/A	2	N/A
6/30/2014	95	-75	N/A	-1	N/A
3/31/2014	91	-40	N/A	-8	N/A
12/31/2013	86	1	N/A	-14	N/A

アナリストによる今後の成長予測

収入対貯蓄率: ASPNは今後 3 年間で収益性が向上すると予測されており、これは貯蓄率 ( 2.4% ) よりも高い成長率であると考えられます。

収益対市場: ASPN今後 3 年間で収益性が向上すると予想されており、これは市場平均を上回る成長と考えられます。

高成長収益: ASPN今後 3 年以内に収益を上げることが予想されます。

収益対市場: ASPNの収益 ( 31.2% ) US市場 ( 8.6% ) よりも速いペースで成長すると予測されています。

高い収益成長: ASPNの収益 ( 31.2% ) 20%よりも速いペースで成長すると予測されています。

一株当たり利益成長率予想

将来の株主資本利益率

将来のROE: ASPNの自己資本利益率が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です

Aspen Aerogels 将来の成長

Future 基準チェック /56

主要情報

今後の成長に関する最新情報

Aspen Aerogels, Inc. Reiterates Earnings Guidance for the Full Year 2024

Price target increased by 7.4% to US$30.30

Price target increased by 11% to US$22.50

Aspen Aerogels, Inc. Revises Earnings Guidance for the Full Year 2024

Consensus estimates of losses per share improve by 11%

Analysts Have Made A Financial Statement On Aspen Aerogels, Inc.'s (NYSE:ASPN) Full-Year Report

Recent updates

Aspen Aerogels, Inc. Reiterates Earnings Guidance for the Full Year 2024

Price target increased by 7.4% to US$30.30

President notifies of intention to sell stock

Key Executive recently sold US$1.2m worth of stock

Insider notifies of intention to sell stock

Price target increased by 11% to US$22.50

Aspen Aerogels, Inc. Revises Earnings Guidance for the Full Year 2024

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

Aspen Aerogels, Inc. to Report Q1, 2024 Results on May 01, 2024

Aspen Aerogels, Inc., Annual General Meeting, May 30, 2024

Health Check: How Prudently Does Aspen Aerogels (NYSE:ASPN) Use Debt?

Aspen Aerogels: Impressive And Intriguing

Aspen Aerogels, Inc. (NYSE:ASPN) Looks Just Right With A 53% Price Jump

Consensus estimates of losses per share improve by 11%

Analysts Have Made A Financial Statement On Aspen Aerogels, Inc.'s (NYSE:ASPN) Full-Year Report

Full year 2023 earnings: EPS exceeds analyst expectations

Aspen Aerogels, Inc. Provides Earnings Guidance for Full Year 2024

Aspen Aerogels, Inc. to Report Q4, 2023 Results on Feb 12, 2024

Aspen Aerogels, Inc. Provides Revenue Guidance for the Fourth Quarter and Year 2023 and Provides Revenue Guidance for the Year 2024

Powering Up The EV Market: Mini Deep Dive On Aspen Aerogels

Why Investors Shouldn't Be Surprised By Aspen Aerogels, Inc.'s (NYSE:ASPN) 40% Share Price Surge

Aspen Aerogels, Inc. has filed a Follow-on Equity Offering in the amount of $75.000012 million.

Aspen Aerogels: Phoenix Rising - Assessing The Shifts, Challenges, And Potential Future Triumphs

Aspen Aerogels (NYSE:ASPN) Is Making Moderate Use Of Debt

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

Aspen Aerogels, Inc. Revises Earnings Guidance for the Year Ending December 31, 2023

Aspen Aerogels, Inc. to Report Q3, 2023 Results on Nov 01, 2023

Aspen Aerogels: Margin Expansion But Still A Lot Of Uncertainties

Aspen Aerogels, Inc. Appoints Santhosh Daniel as Chief Accounting Officer

Independent Director recently bought US$308k worth of stock

Aspen Aerogels, Inc. Announces Executive Changes

The Price Is Right For Aspen Aerogels, Inc. (NYSE:ASPN) Even After Diving 25%

Consensus EPS estimates upgraded to US$1.05 loss, revenue downgraded

President recently bought US$171k worth of stock

New major risk - Financial position

Second quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Aspen Aerogels, Inc. Revises Earnings Guidance for the Full Year 2023

Aspen Aerogels: Not Insulating Investors From The Cold

First quarter 2023 earnings: EPS exceeds analyst expectations

Aspen Aerogels, Inc. Provides Earnings Guidance for the Year 2023

Price target decreased by 9.9% to US$25.67

Is Aspen Aerogels (NYSE:ASPN) Weighed On By Its Debt Load?

Full year 2022 earnings: EPS and revenues exceed analyst expectations

Aspen Aerogels, Inc. Provides Earnings Guidance for Full Year 2023

Aspen Aerogels Q4 results beat estimates, co guides FY 2023 revenue in-line

Aspen Aerogels, Inc. to Report Q4, 2022 Results on Feb 15, 2023

Aspen Aerogels: No Reason To Be In A Hurry, Ample Headwinds In 2023

Forecast to breakeven in 2025

Aspen Aerogels, Inc. has completed a Follow-on Equity Offering in the amount of $240.000001 million.

Price target decreased to US$29.60

Consultant notifies of intention to sell stock

Aspen Aerogels, Inc. Appoints Katie Kool to Board of Directors

Third quarter 2022 earnings: EPS and revenues miss analyst expectations

Aspen Aerogels, Inc. Provides Earnings Guidance for the Year Ending December 31, 2022

Aspen Aerogels (NYSE:ASPN) Has Debt But No Earnings; Should You Worry?

Aspen Aerogels reports Q3 earnings miss; narrows FY22 earnings guidance

Aspen Aerogels, Inc. to Report Q3, 2022 Results on Oct 26, 2022

Consultant notifies of intention to sell stock

Aspen Aerogels, Inc. Appoints James Sweetnam to Board of Directors

Price target decreased to US$36.90

Second quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Aspen Aerogels, Inc. Provides Earnings Guidance for the Year 2022

Is Aspen Aerogels (NYSE:ASPN) A Risky Investment?

Aspen Aerogels, Inc. to Report Q2, 2022 Results on Jul 27, 2022

Price target decreased to US$44.20

Price target decreased to US$45.70

Aspen Aerogels soars ~56% following its decision to not advance with stock and debt offering

Consensus forecasts updated

Aspen Aerogels, Inc. Provides Full Year Financial Outlook 2022